Related Experiment Videos

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia

R Pieters¹, E Klumper, G J Kaspers

¹Free University Hospital, Department of Pediatric Hematology/Oncology, Amsterdam, Netherlands.

Critical Reviews in Oncology/Hematology

|January 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Higher frequency of public hospital utilisation for rheumatological conditions by First Nations people in Western Sydney.

Internal medicine journal·2025

Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study.

International journal of antimicrobial agents·2023

Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.

European journal of cancer (Oxford, England : 1990)·2021

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.

BMC pediatrics·2021

Ten Bird Species, Six Guilds, Three Habitats, and 59 Chlorinated and Brominated POPs: What do 64 Eggs from the Largest Economic Hub of Southern Africa tell us?

Archives of environmental contamination and toxicology·2021

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia.

BMC cancer·2020

See all related articles